Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Immunic, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 57 | 2 | 62 | +7 |
| Shares | 55.8M | 2.79M | 56.0M | +2.95M (+5.6%) |
| Value | $62.1M | $3.10M | $92.4M | +$33.4M (+56.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Immunic, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 2,144,743 | $3.54M | 0.01% |
| BlackRock, Inc. | 684,663 | $1.13M | 0.00% |
| Woodline Partners LP | 118,652 | $195.8K | 0.00% |
| Citigroup Inc | 108,187 | $178.5K | 0.00% |
| Acadian Asset Management LLC | 96,548 | $158.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 41,062 | $67.8K | 0.00% |
| Virtu Financial LLC | 30,359 | $50.0K | 0.00% |
| Cantor Fitzgerald, L. P. | 13,000 | $21.4K | 0.00% |
| Balboa Wealth Partners | 12,000 | $19.8K | 0.00% |
| Wolverine Trading, LLC | 11,693 | $18.1K | 0.00% |
| PFG Investments, LLC | 10,500 | $17.3K | 0.00% |
| Capital Performance Advisors LLP | 21 | $35 | 0.00% |
Sold out (5)
Institutions that held Immunic, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Jefferies Financial Group Inc. | 331,774 | $368.3K |
| Bank of Montreal | 284,109 | $321.0K |
| Squarepoint Ops LLC | 22,054 | $24.5K |
| Summit Trail Advisors, LLC | 21,600 | $24.0K |
| Group One Trading, L.P. | 42 | $47 |
Not filed for Q3 2024 yet (2)
Institutions that held Immunic, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Gratus Capital LLC | 2,109,664 | $2.34M |
| BlackRock Inc. | 679,343 | $754.1K |